Summary
Data on forged prescriptions in Sweden in 1982–1986 were studied as an indicator in an epidemiological survey of medication abuse.
The annual number of prescription forgeries doubled during the 5-year period. Psychotropic drugs accounted for 62% and analgesics for 25% of all forgeries. Benzodiazepines were the major single drug group, comprising 52% of all forgeries during the period. The major benzodiazepines on the market in Sweden (diazepam, oxazepam, nitrazepam and flunitrazepam) were the subject of largest number of forgeries.
When calculated in relation to the utilization (either total sales or the number of prescriptions), the analgesics codeine, pentazocine and ketobemidone were clearly at the head of the list, suggesting greater abuse liability of these drugs.
It is suggested that the data on forged prescriptions can be used as a “signalling mechanism” in epidemiological surveillance of medication abuse, aimed at detecting changes in the prevalence as well as in the pattern of abuse.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Griffiths RR, McLeod DR, Bigelow GE, Liebson IA, Roache JD (1984) Relative abuse liability of diazepam and oxazepam: Behavioral and subjective dose effects. Psychopharmacology 84: 147–154
Strang J (1985) Abuse of buprenorphine. Lancet 2: 725
US Dept of Health Education and Welfare. Drug Watch, Rockville, Md: NIDA 1977
US Dept of Health Education and Welfare. Drug Abuse Warning Network, phase VI report. May 1977–April 1978. Rockville, Md: NIDA 1979
Ghodse AH, Edwards G, Stapleton J, Baderman H, Brooks D, Dallos V, Hoy MA, Radford RC, Vyse JA, Williams DJ (1981) Drug-related problems in London accident and emergency departments. A twelve month survey. Lancet 2: 859–862
Bergman U (1986) Epidemiologisk uppföljning av läkemedelsmissbruk. (Epidemiological surveillance of drug abuse) Sv Läkaresällskapets Handlingar, Hygiea 95 (6): 192
Bergman U, Griffiths RR (1986) Relative abuse of diazepam and oxazepam: prescription forgeries and theft/loss reports in Sweden. Drug Alcohol Depend 16: 293–301
Swedish Drug Statistics 1986. National Corporation of Pharmacies, Stockholm 1987
Bergman U, Sjöqvist F (1984) Measurement of drug utilization in Sweden: Methodological and clinical implications. In: Agenäs I, Sjöqvist F (eds) Drug utilization studies — Implications for medical care. Acta Med Scand 683 [Suppl]: 15–22
Wessling A (1987) Continuous recording of drug prescribing in Sweden 1974–1983. Methods and examples of utilization of data. Eur J Clin Pharmacol 33: 7–13
Persson G (1981) Lyckas förfalskningar av recept? Läkartidningen 78: 3262
Drug utilization in the US — 1983. Fifth Annual Review. Department of Health and Human Services, February 1985
Author information
Authors and Affiliations
Additional information
At the time of the study also of the Department of Drugs, National Board of Health and Welfare, Uppsala, Sweden
Rights and permissions
About this article
Cite this article
Bergman, U., Dahl-Puustinen, M.L. Use of prescription forgeries in a drug abuse surveillance network. Eur J Clin Pharmacol 36, 621–623 (1989). https://doi.org/10.1007/BF00637747
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00637747